In a patient with massive ascites due to an ovarian tumor and a preserved left ventricular ejection fraction, can the ascites cause an elevated N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level?

Can Massive Ascites from an Ovarian Tumor Elevate NT-proBNP?

Yes, massive ascites from an ovarian tumor can contribute to elevated NT-proBNP levels, but this elevation is typically modest compared to cardiac causes, and the preserved ejection fraction in your patient suggests the ascites itself is not causing significant cardiac stress.

Understanding NT-proBNP Elevation in Non-Cardiac Ascites

The key guideline evidence directly addresses this scenario. Advanced liver cirrhosis with ascites is explicitly listed as a condition that increases natriuretic peptides 1. However, the mechanism and magnitude differ substantially from cardiac causes.

Critical Distinction: Cirrhotic vs. Malignant Ascites

Research specifically examining this question reveals an important pattern:

• In cirrhotic patients undergoing large volume paracentesis, NT-proBNP levels actually decreased during fluid removal (by 77.3 pg/mL at 2L drainage and 94.3 pg/mL at completion) 2
• In contrast, cancer patients with malignant ascites showed increases in NT-proBNP during paracentesis (10.5 pg/mL at 2L and 77.2 pg/mL at completion) 2

This paradoxical finding suggests that malignant ascites from ovarian tumors behaves differently than cirrhotic ascites and may cause modest NT-proBNP elevation through mechanisms other than direct cardiac stretch.

Interpreting Your Patient's Elevated NT-proBNP

Given preserved LVEF, consider this algorithmic approach:

1. Assess the Magnitude of Elevation

• Modest elevation (300-900 pg/mL): More likely related to ascites, renal clearance issues, or non-cardiac factors
• Marked elevation (>1800 pg/mL): Suggests true cardiac pathology despite preserved LVEF, particularly diastolic dysfunction or right ventricular strain 3

2. Look for Cardiac Dysfunction Beyond LVEF

Even with preserved ejection fraction, evaluate for:

• Diastolic dysfunction (elevated E/E' ratio, left atrial enlargement)
• Right ventricular dysfunction from increased intra-abdominal pressure
• Elevated filling pressures from mechanical compression by massive ascites
• Atrial fibrillation (independently elevates NT-proBNP) 4

3. Consider Non-Cardiac Contributors

The guidelines emphasize that NT-proBNP elevation in non-heart failure states is not a "false positive" but reflects real pathophysiology 3, 5. In your patient, assess:

• Renal function: NT-proBNP clearance is 55-65% renal; even moderate dysfunction elevates levels 1
• Malnutrition/hypoalbuminemia: Independently associated with elevated NT-proBNP 4
• Inflammatory state: Elevated CRP correlates with higher NT-proBNP 4
• Mechanical cardiac compression: Massive ascites increases intra-abdominal pressure, potentially affecting venous return and right heart function

Clinical Pitfalls to Avoid

Do not dismiss elevated NT-proBNP simply because LVEF is preserved. The evidence shows that:

• HFpEF patients can have significantly elevated NT-proBNP with normal systolic function 3, 6
• Patients with HFpEF and "normal" NT-proBNP (<125 pg/mL) still have 2.7-fold higher mortality risk than controls 6
• The presence of massive ascites causing elevated intra-abdominal pressure can create genuine cardiac stress manifesting as elevated filling pressures during exercise, even if resting LVEF appears normal 6

Practical Recommendation

In a patient with massive ovarian tumor ascites and preserved LVEF:

1. The ascites likely contributes modestly to NT-proBNP elevation through mechanical effects and altered clearance, but this is not the primary concern
2. More importantly, assess for occult cardiac dysfunction (diastolic dysfunction, RV strain, elevated filling pressures) that may be masked by focusing only on LVEF
3. Check renal function, albumin, and inflammatory markers as these independently affect NT-proBNP levels 4
4. Consider therapeutic paracentesis and remeasure NT-proBNP after drainage—if levels drop significantly, the ascites was contributing; if they remain elevated or rise, focus on cardiac evaluation 2
5. Do not use standard heart failure cutoffs without adjustment—the same NT-proBNP level predicts different risks depending on comorbidities 7

The elevated NT-proBNP warrants investigation but should not automatically trigger aggressive heart failure therapy in the absence of other cardiac findings.